. (1973). Thorax, 28,[596][597][598][599][600]. Isocyanate asthma: respiratory symptoms caused by diphenyl-methane di-isocyanate. We investigated 57 employees of a factory where diphenyl-methane di-isocyanate (MDI) was used to prepare the materials for making rigid polyurethane foam. Four employees had developed hypersensitivity to MDI. Two had severe, and one moderate asthma, while the fourth had symptoms resembling the delayed hypersensitivity type of reaction. Ten other employees had experienced unpleasant, mainly respiratory, irritant effects from MDI vapour.
Isocyanates are chemicals used in the production of polyurethane products. The hazards of these substances are well known (Munn, 1965; Lancet, 1966) but some appear to be less toxic than others. Diphenyl-methane 4,41, di-isocyanate [CH2 (C6H4NCO)2 or MDI] is less volatile than other isocyanates commonly used in industry and has been considered to be of low toxicity (Munn, 1965) .
In March 1971, two employees of a factory which prepared the chemicals needed to produce rigid polyurethane mouldings became ill after molten MDI was accidentally spilt in the factory. It appeared that all the employees were exposed to MDI vapour from time to time, and this prompted an investigation of all the staff.
METHODS
The factory was visited on two occasions at an interval of eight months. All the employees were examined on both occasions. At the first visit, 44 employees were interviewed after completing a questionnaire. Forced vital capacity (FVC) and forced expiratory volume in one second (FEVy) were measured with a Vitalograph spirometer. Predicted normal values were obtained from the nomogram derived from the formula of Cournand (Documenta Geigy Scientific Tables, 6th  Edition , Basle, 1962) .
On the second visit the same procedure was followed. Eight employees had left the factory, and there were 13 new employees, all of whom had been employed for at least three months. Thirty-six people were therefore re-examined, and a total of 57 were examined during the survey.
RESULTS
Fourteen of the 57 employees reported symptoms whenever they were in contact with MDI vapour (Table I) . Three had severe symptoms, and their case histories are described below. One other employee had moderate but increasing tightness of the chest on repeated contact with MDI vapour. Another described wheezing, and others described tightness of the chest, headache, diarrhoea, or sore throat.
Twenty-six employees were in daily contact with MDI, and 12 of these noticed symptoms (45%). There was no evidence of deterioration in the spirometric values of those retested after eight months. The results in the 12 people affected by MDI who were retested are given in Table III . Two affected employees were not retested. One woman of 65 retired shortly after the time of the first examination, and one employee affected by MDI had joined the factory after our first visit. Thirteen employees had a past history of possible allergic symptoms (Table IV) . Eight were in daily contact with MDI and seven of these had symptoms from it (Table V) .
Thirty-nine employees had a past history of bronchitis. Nineteen of these were in potential daily contact with MDI, and 10 of these (53%) had symptoms from it. There was no history of allergy, although his son had hay fever. He did not smoke but sometimes had bronchitis with 'colds'. Skin tests to seven common allergens were negative. FVC was 3,600 ml (96% predicted), FEV1 3,050 ml, FEV1/FVC=85%. CASE 4 One man complained of moderate but increasingly severe wheezing after contact with spilt MDI. CASES 5 to 12 Eight people complained of tightness of the chest after contact with MDI vapour. All but one were explicit that they did not wheeze. CASES 13 and 14 One person complained of headaches and slight diarrhoea, and one of sore throats after contact with spilt MDI.
DISCUSSION
Isocyanates react with a wide variety of compounds containing active hydrogen atoms. Compounds containing hydroxyl groups readily form esters of substituted carbamic acid (urethanes), and the name 'polyurethane' has become accepted as a generic term to cover all the industrial products made from isocyanates (Buist, 1970) . The isocyanates most widely used in industry are the di-isocyanatestolylene di-isocyanate (TDI) and diphenyl-methane di-isocyanate (MDI). The hazards of isocyanates have been widely reported (Lancet, 1966) , but most reports have been concerned with the effects of the more toxic TDI. This has been shown to cause a fall in FEV1 in concentrations well below the threshold limit value of 0 02 parts per million (Peters, Murphy, Pagnotto, and van Ganse, 1968) . Continued exposure to low concentrations of TDI may also cause cumulative changes of this nature (Peters, Murphy, and Ferris, 1969; Adams, 1970) .
In the present study, the concentrations of MDI to which individual workers were exposed were not known. The vapour pressure of solid MDI is low (Munn, 1970) , but splashes or a spray of molten MDI may allow the inhalation of droplets. Respiratory symptoms may occur from a direct irritant effect of MDI, and occasional cases of sensitization have been reported (Longley, 1964; Munn, 1965) .
We found that 45% of workers frequently exposed to MDI had observed toxic effects from it. In most cases these effects appeared to be those of an irritant, mainly affecting the respiratory system and causing what was described as 'tightness of the chest'. We found no evidence of permanent deterioration, judged by spirometry, during a period of eight months.
However, four people (29 %) gave histories which suggested that they had developed hypersensitivity to MDI (cases 1 to 4). In three cases (1, 2, and 4) asthma was precipitated by contact with MDI, and in one case the asthma was severe and could be caused by concentrations of MDI which could not be detected by available instruments. The wheezing responded to bronchodilators, and in the one patient in whom it was tried (case 2) di-sodium cromoglycate appeared to afford some protection.
In one patient with severe symptoms (case 3), the reaction was not that of asthma but of symp-Isocyanate asthma: respiratory symptoms caused by diphenyl-methane di-isocyanate toms resembling those of the delayed hypersensitivity type of reaction such as may occur with certain organic dusts, as in 'farmer's lung'. The symptoms were of such severity that the patient, quite rightly, refused to go anywhere near MDI.
This type of reaction to MDI has not been described before.
The immunology of hypersensitivity reactions to isocyanates has not been fully explained. Circulating antibodies have been detected in individuals sensitive to TDI (Taylor, 1970) , but Konzen, Craft, Scheel, and Gorski (1966) failed to induce hypersensitivity or find circulating antibodies using MDI, although Stevens (1967) Of those in daily contact with MDI, 73 % had a history of previous bronchitis; 53% of these developed symptoms from MDI, and only 28% of those without a history of bronchitis noticed symptoms (Table V) . These figures suggest an association but are not statistically significant. Previously, a history of bronchitis has been found to predispose to symptoms from TDI (Peters, 1970) . Eight people had a history of 'allergy' (Tables IV and V) ; seven of these were affected by MDI (88%) as compared to 28% of the 18 without such a history. This association is statistically significant, but the clinical significance is less obvious since only two of the seven affected had hypersensitivity, the others suffering only irritant effects.
Until more information is available, it seems advisable that employees with a history of allergy or bronchitis should not come into contact with MDI. Although MDI is undoubtedly safer than TDI, the fact that it may cause severe reactions due to the development of hypersensitivity does not appear to be generally appreciated. Since becoming aware of this possibility, one of us (A. R. T.) has been approached by two other firms producing rigid polyurethane foam for advice as to simple precautions to take when handling MDI. These firms had not previously been aware that there was any significant potential hazard to health. We discussed the use of MDI with a sales engineer concerned solely with equipment for producing rigid polyurethane foam products, and he described extremely careless handling of molten MDI, particularly in certain North American factories. He had experienced severe irritant effects lasting two or three weeks but did not appear to have developed hypersensitivity.
We believe that our experience has confirmed that there is a significant hazard from MDI, but that this can be controlled if the correct precautions are taken. We wish to thank Miss H. Gimblett for invaluable technical assistance, and to express our appreciation of the willing co-operation of the manager and personnel of the factory involved. 
